1. Home
  2. BGX vs ACOG Comparison

BGX vs ACOG Comparison

Compare BGX & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Long Short Credit Income Fund

BGX

Blackstone Long Short Credit Income Fund

HOLD

Current Price

$10.81

Market Cap

135.2M

Sector

Finance

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$6.58

Market Cap

110.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGX
ACOG
Founded
N/A
2000
Country
United States
Canada
Employees
N/A
57
Industry
Trusts Except Educational Religious and Charitable
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
135.2M
110.4M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
BGX
ACOG
Price
$10.81
$6.58
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.00
AVG Volume (30 Days)
48.2K
29.1K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$139.22
Revenue Next Year
N/A
$134.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.38
$4.50
52 Week High
$12.65
$10.88

Technical Indicators

Market Signals
Indicator
BGX
ACOG
Relative Strength Index (RSI) 41.17 59.70
Support Level $10.76 $6.46
Resistance Level $10.97 $6.89
Average True Range (ATR) 0.06 0.39
MACD 0.00 0.08
Stochastic Oscillator 29.41 72.64

Price Performance

Historical Comparison
BGX
ACOG

About BGX Blackstone Long Short Credit Income Fund

Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. The company's seeks to achieve its investment objectives by employing a dynamic long-short strategies in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: